Robert Baffi
Net worth: - $ as of 31/05/2026
Net worth: - $ as of 31/05/2026
Robert A. Baffi is Director at the National Institute for Bioprocessing Research & Training.
He is Director at Neurogene, Inc. (New York) since 2020 and Independent Director at Neurogene, Inc. since 2023.
He is Venture Partner at Samsara BioCapital LLC and Samsara, Inc., both since 2021.
Former roles include Director at Genentech, Inc. in 2000, Director at Humanigen, Inc. from 2014 to 2015, Director at Bionic Sight, Inc. from 2020 to 2024, Independent Director at Mosaic ImmunoEngineering, Inc., Executive Vice President-Technical Operations at BioMarin Pharmaceutical, Inc. from 2010 to 2020, and Research Scientist at Cooper Biomedical, Inc. Education includes undergraduate, graduate, and doctorate degrees from City University of New York conferred in 1983, and an MBA from Regis University conferred in 2001.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 07/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 31/03/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SAMSARA INC. | Corporate Officer/Principal | 01/03/2021 |
National Institute for Bioprocessing Research & Training
National Institute for Bioprocessing Research & Training BiotechnologyHealth Technology Operates as a training and research center for biopharmaceutical manufacturing industry | Director/Board Member | - |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Director/Board Member | 17/09/2020 |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Private Equity Investor | 01/03/2021 |
| Companies | Position | End |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 04/05/2020 |
| HUMANIGEN, INC. | Director/Board Member | 20/11/2015 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Director/Board Member | 01/01/2000 |
| MOSAIC IMMUNOENGINEERING, INC. | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Humanigen, Inc.
Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
City University of New York
City University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regis University
Regis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institute for Bioprocessing Research & Training
National Institute for Bioprocessing Research & Training BiotechnologyHealth Technology Operates as a training and research center for biopharmaceutical manufacturing industry | Health Technology |
Cooper Biomedical, Inc.
Cooper Biomedical, Inc. Medical SpecialtiesHealth Technology Manufactures and sells medical devices | Health Technology |
Samsara, Inc.
Samsara, Inc. Packaged SoftwareTechnology Services Develops a connected operations platform that connects people, IoT devices and systems | Technology Services |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Operates as a clinical stage company that develops genetic medicines for neurological diseases | Health Technology |
Mosaic ImmunoEngineering, Inc.
Mosaic ImmunoEngineering, Inc. BiotechnologyHealth Technology Develops immunotherapy pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions